By the China Pharmaceutical Equipment Industry Association 41 Spring 2011 session of the National Pharmaceutical Machinery Exposition, 2011 29 May to 1 June was held in Shenyang International Exhibition Centre. By then, Jiangxi shaped Pharmaceutical Machinery Co., Ltd. invites all relevant business leaders to come to visit and guide.
Jiangxi Pharmaceutical Machinery Co., Ltd. is shaped in the Chinese Pharmaceutical Equipment Association and the Jiangxi Academy of Sciences for their support and help of the rise of a new high-tech innovative enterprises.digital blood pressure monitor Companies starting point, strong technical force, with more than specializing in pharmaceutical research specialist equipment, has formed a research, development, manufacturing, sales and service as one of the modern enterprise.
Produced JQT-1000 type, digital thermometer manufacturer JQT-1250-type closed sugar coating machine, JBY-1000 type, JBY-1250 High-efficiency coating machine, JKR-550 type clean air hot air, JSC-250 dust filter type water curtain and other products have received the quality of mechanical and electrical products of Jiangxi Medical Device Test Center awarded the certificate. Full closure of the sugar coating machine which has received national patents, is the sugar coating machine series of the most advanced equipment, water, dust filter screen machine at the leading domestic pharmaceutical dust removal equipment, digital thermometer has been reported to the national invention patent.
EU's new regulations into effect herbal medicine export orders blocked
A piece of paper instructions, so the 109th Canton Fair, Chinese domestic suppliers and buyers have become uneasy European Union, the two sides do not rush orders, more just meet to discuss countermeasures.
Introduced in 2004 in the European Union "traditional herbal registration process instruction" ("the Directive") this year on May 1 into effect. "Directive" provides all the herbal manufacturers must be 30 April 2011 to complete the registration, otherwise not allowed in the sale and use within the European Union.
Industry sources, currently there is not a proprietary pharmaceutical product to get approval from the European Union because of the EU technical information required by the standard issues related to medicine, there are qualitative and quantitative composition of the target, which is precisely the combination of medicine in the short board.
"Command" the implementation date, to coincide with the opening of the third trade fair, the domestic Chinese enterprises in the export orders the peak of the difficulties encountered, many companies can not rush them registering orders.
As of May 2, the Canton Fair turnover intention medicine is only 500 million dollars, and some of these will be "health food" status to enter the EU market. In view of the uncertain situation, a number of Chinese enterprises to increase the domestic market development efforts of other.
Regional Manager of Beijing Tong Ren Tang International Co., Ltd. Dong Ling told reporters that this year's trade with European customers or to negotiate, but has no medicine order transaction.
In recent days, Chinese patent medicines Fair Trading on the European Union showed a cool scene, Tianjin Zhongxin Pharmaceutical and other major domestic Chinese enterprises and proprietary trading for the EU's single orders only a few lines. Wuhan Guo Moxibustion Technology Development Co., Ltd. Foreign Trade Department Manager, Xiao Jun, pointed out that the company's agents in some countries of the EU will face the plight of out of stock, both sides are looking for solutions.
Not only drugs, multi-country European Union on the way to sales of herbal food products have also been strictly limited. Chinese Investment and Development Co., Ltd. Shenzhen Sanjiu manager Wang Yonggang, said that any medicinal ingredients from plants are classified as the production of herbal medicine, traditional Chinese medicine so difficult to pass food or health products up to enter the European market. To this end, the company in the consolidation of traditional Chinese medicine in Southeast Asia and Australia, and other overseas markets, while also increasing efforts to develop the North American market.
However, the reporter learned that the Canton Fair, and some traditional Chinese medicine as "health products" as yet to enter the EU market. Shanghai Medicines and Health Products Import & Export Co., Ltd. General Manager's Office Director Chen Kang said that at present, raw medicinal herbs, and some health care products not affected significantly on these products in the EU Procurement Fair to continue to the next one, nutritional health goods entering the EU market risk than functional health products to be small.
"Many Chinese factories can not take up the increased costs from the current situation," instructions "on the Chinese production plant is greater than the impact of foreign trade companies, foreign trade companies is relatively flexible, market conditions can be adjusted for product variety." Chen Kang said.
The end of 2010, Beijing Tong Ren Tang, Guangzhou and Lanzhou Foci Pharmaceutical Qixing medicine, and other domestic companies preparing applications for registration to the EU, but registration is more costly, difficult to cross the threshold of the relevant technical and other reasons, so far still no case of domestic medicine to drugs in the EU as up.
Chinese Medicines and Health Products Import and Export Chamber of Commerce vice president of Liu Zhang told this reporter, for the matter, although the Association has continued with the major countries of the EU pharmaceutical regulatory departments, trying to extend the EU's "orders" time for the entry into force of Chinese enterprises, but to promote foreign legislative difficult. Sweden and China were responsible Jinbo Medical Group, said that in the future conduct of medicine in Europe may fall into "There is no medicine doctors," a difficult situation.
"Instructions" of the implementation of the development of Chinese medicine to the EU will also have impact. It is reported that nearly 10 million in the EU of Chinese medicine practitioners will face the risk of transition or unemployment, including local Chinese medicine agent.